#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myocarditis Retinopathy of prematurity Idiopathic inflammatory myopathy Albright's disease Erythema Thrombotic thrombocytopenic purpura Multifocal motor neuropathy Small intestine neuroendocrine tumour Plasma cell myeloma refractory Thyroid cancer metastatic Nasopharyngeal cancer Immune thrombocytopenia Macular telangiectasia Ewing's sarcoma metastatic Acute myeloid leukaemia refractory More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Trials in Disease Leiomyosarcoma recurrent – Treatment Cerebral arteriovenous malformation haemorrhagic – Life with Disease Chondrosarcoma metastatic – Basic Information Waldenstrom’s macroglobulinaemia refractory – Life with Disease Glomerulonephritis membranoproliferative – Basic Information Marginal zone lymphoma – Basic Information Glycogen storage disease type V – Diagnostics Pelizaeus-Merzbacher disease – Life with Disease X-linked lymphoproliferative syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olopatadine Hydrochloride Desflurane Anhydrous Docetaxel Phleum Pratense Ulipristal Acetate Naloxegol Oxalate PAPAVERINE HYDROCHLORIDE Bemnifosbuvir Hemisulfate Tilsotolimod Sodium Tacrolimus Calcium Lactate Gluconate Paxalisib Zolbetuximab Potassium Canrenoate Mitoxantrone Osimertinib Gen1055 TRIGLYCERIDES MEDIUM CHAIN Ly3437943 Sodium Gsk3915393 More therapies…

    Learn about Your Condition

    Mesothelioma malignant Addison's disease Myxofibrosarcoma Red blood cell abnormality Haemorrhagic stroke Cirrhosis alcoholic Corneal graft failure Stress urinary incontinence Small fibre neuropathy Pneumonia bacterial Meniscus injury Cough Neurodevelopmental disorder Sarcoma metastatic Peripheral artery stenosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Primary immunodeficiency syndrome

  • Long-term safety and effectiveness study of leniolisib for patients with primary immunodeficiency and immune system problems

    Recruiting

    2 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Leniolisib Phosphate
    Spain

  • Autologous CD4+ T-Cell Gene Therapy for X-linked Hyper-IgM Syndrome Type 1 in Patients with X-linked Hyper-IgM Syndrome Type 1

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
    • HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA]
    Italy

  • Study on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Hyaluronidase (Human Recombinant)
    • Human Normal Immunoglobulin
    Czechia Denmark Germany Greece The Netherlands Poland +2

  • Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Hyaluronidase (Human Recombinant)
    • Human Normal Immunoglobulin
    Czechia Denmark Germany Greece The Netherlands Poland +2

  • Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Selective polysaccharide antibody deficiency
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Human Normal Immunoglobulin
    The Netherlands

  • Study on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Germany Hungary Italy Poland Slovakia

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!